Detalhe da pesquisa
1.
Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.
Pediatr Blood Cancer
; 70(11): e30645, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37638847
2.
Making Improvements in the ED: Does ED Busyness Affect Time to Antibiotics in Febrile Pediatric Oncology Patients Presenting to the Emergency Department?
Pediatr Emerg Care
; 34(5): 310-316, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27749799
3.
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study.
Lancet Haematol
; 11(5): e358-e367, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555923
4.
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma.
Blood Adv
; 6(4): 1255-1263, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666347
5.
The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL.
Blood Cancer J
; 9(2): 10, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670684
6.
Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways.
Cell Cycle
; 13(6): 1006-14, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552822